Selux Diagnostics receives additional $14.6M in BARDA funding after successfully completing first clinical trialJune 14, 2021
Selux Diagnostics Receives Additional $14.6 Million in BARDA Funding After Successfully Completing First Clinical TrialJune 9, 2021
Selux Diagnostics Receives $9.6 Million in Additional Funding, Speeding Development of Breakthrough Rapid AST PlatformApril 27, 2020
ECCMID 2020 Alert: Selux Diagnostics Hosting Integrated Symposium at 30th European Congress of Clinical Microbiology & Infectious DiseasesFebruary 18, 2020
